Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
BMC Cancer
Published in: BMC Cancer 1/2013

Open Access 01-12-2013 | Research article

Human papillomavirus genotypes distribution in 175 invasive cervical cancer cases from Brazil

Authors: Cristina Mendes de Oliveira, José Humberto Tavares Guerreiro Fregnani, Jesus Paula Carvalho, Adhemar Longatto-Filho, José Eduardo Levi

Published in: BMC Cancer | Issue 1/2013

Login to get access

Abstract

Background

Invasive cervical cancer is the second most common malignant tumor affecting Brazilian women. Knowledge on Human Papillomavirus (HPV) genotypes in invasive cervical cancer cases is crucial to guide the introduction and further evaluate the impact of new preventive strategies based on HPV. We aimed to provide updated comprehensive data about the HPV types’ distribution in patients with invasive cervical cancer.

Methods

Fresh tumor tissue samples of histologically confirmed invasive cervical cancer were collected from 175 women attending two cancer reference hospitals from São Paulo State: ICESP and Hospital de Câncer de Barretos. HPV detection and genotyping were performed by the Linear Array HPV Genotyping Test (Roche Molecular Diagnostics, Pleasanton,USA).

Results

170 out of 172 valid samples (99%) were HPV DNA positive. The most frequent types were HPV16 (77.6%), HPV18 (12.3%), HPV31 (8.8%), HPV33 (7.1%) and HPV35 (5.9%). Most infections (75%) were caused by individual HPV types. Women with adenocarcinoma were not younger than those with squamous cell carcinoma, as well, as women infected with HPV33 were older than those infected by other HPV types. Some differences between results obtained in the two hospitals were observed: higher overall prevalence of HPV16, absence of single infection by HPV31 and HPV45 was verified in HC-Barretos in comparison to ICESP patients.

Conclusions

To our knowledge, this is one of the largest studies made with fresh tumor tissues of invasive cervical cancer cases in Brazil. This study depicted a distinct HPV genotype distribution between two centers that may reflect the local epidemiology of HPV transmission among these populations. Due to the impact of these findings on cervical cancer preventive strategies, extension of this investigation to routine screening populations is warranted.
Appendix
Available only for authorised users
Literature
1.
Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM: GLOBOCAN 2008 v2.0, Cancer Incidence and Mortality Worldwide: IARC CancerBase n .10 [Internet]. 2010, Lyon, France: International Agency for Research on Cancer, http://​globocan.​iarc.​fr,
2.
INCA: Estimativa 2012 – Incidência de Câncer no Brasil. 2011, Rio de Janeiro: Ministério da Saúde
3.
Bosch FX, Lorincz A, Muñoz N, Meijer CJL, Shah KV: The causal relation between human papilomavírus and cervical cancer. J Clin Pathol. 2002, 55: 244-265. 10.1136/jcp.55.4.244.CrossRefPubMedPubMedCentral
4.
De Villiers EM, Fauquet C, Broker TR, Bernard HU, Hausen H: Classification of papillomaviruses. Virology. 2004, 324: 17-27. 10.1016/j.virol.2004.03.033.CrossRefPubMed
5.
Bernard HU, Burk RD, Chen Z, Van Doorslaer K, Hausen H, De Villiers EM: Classification of papillomaviruses (PVs) based on 189 PV types and proposal of taxonomic amendments. Virology. 2010, 401: 70-79. 10.1016/j.virol.2010.02.002.CrossRefPubMedPubMedCentral
6.
Muñoz N, Bosch FX, De Sanjosé S, Herrero R, Castellsagué X, Shah KV, Snijders PJF, Meijer CJLM: Epidemiologic Classification of Human Papillomavirus Types Associated with Cervical Cancer. N Engl J Med. 2003, 348: 518-527. 10.1056/NEJMoa021641.CrossRefPubMed
7.
Bouvard V, Baan R, Straif K, Grosse Y, Secretan B, El Ghissassi F, Benbrahim-Tallaa L, Guha N, Freeman C, Galichet L, Cogliano V, WHO International Agency for Research on Cancer Monograph Working Group: A review of human carcinogens-part B: biological agents. Lancet Oncol. 2009, 10: 321-322. 10.1016/S1470-2045(09)70096-8.CrossRefPubMed
8.
Walboomers JMM, Jacobs MV, Manos MM, Bosch FX, Kummer JA, Shah KV, Snijders PJF, Peto J, Meijer DJLM, Muñoz N: Human Papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol. 1999, 189: 12-19. 10.1002/(SICI)1096-9896(199909)189:1<12::AID-PATH431>3.0.CO;2-F.CrossRefPubMed
9.
Schiffman M, Kjaer SK: Natural history of anogenital human papilomavírus infection and neoplasia. J Natl Cancer Inst Monogr. 2003, 31: 14-19.CrossRefPubMed
10.
Schiller JT, Castellsagué X, Villa LL, Hildesheim A: An update of prophylactic human papillomavirus L1 virus-like particle vaccine clinical trial results. Vaccine. 2008, 26 (Suppl 10): K53-K61.CrossRefPubMedPubMedCentral
11.
De Sanjosé S, Quint WGV, Alemany L, Geraets DT, Klaustermeier JE, Lloveras B, Tous S, Felix A, Bravo LE, Shin HR, Vallejos CS, De Ruiz PA, Lima MA, Guimera N, Clavero O, Alejo M, Llombart-Bosch A, Cheng-Yang C, Tatti AS, Kasamatsu TE, Iljazovic E, Odida M, Prado R, Seoud M, Usubutun MGA, Jain A, Suarez GAH, Lombardi LE, Banjo A, Menéndez C, et al: Human papillomavirus genotype attribution in invasive cervical cancer: a retrospective cross-sectional worldwide study. Lancet Oncol. 2010, 11: 1048-1056. 10.1016/S1470-2045(10)70230-8.CrossRefPubMed
12.
Li N, Franceschi S, Howell-Jones R, Snijders PJF, Clifford GM: Human Papillomavirus type distribution in 30,848 invasive cervical cancers worldwide: variation by geographical region, histological type and year of publication. Int J Cancer. 2011, 128: 927-935. 10.1002/ijc.25396.CrossRefPubMed
13.
Eluf-Neto J, Booth M, Muñoz N, Bosch FX, Meijer CJLM, Walboomers JMM: Human papillomavirus and invasive cervical cancer in Brazil. Br J Cancer. 1994, 69: 114-119. 10.1038/bjc.1994.18.CrossRefPubMedPubMedCentral
14.
Noronha V, Mello W, Villa L, Brito A, Macedo R, Bisi F, Mota R, Sassamoto K, Monteiro T, Linhares A: Papilomavírus humano associado a lesões de cérvice uterina. Rev Soc Bras Med Trop. 1999, 32: 235-240. 10.1590/S0037-86821999000300003.CrossRefPubMed
15.
Lorenzato F, Ho L, Terry G, Singer A, Santos LC, Batista RL, Lubambo T: The use of human papillomavirus typing in detection of cervical neoplasia in Recife (Brazil). Int J Gyn Cancer. 2000, 10: 143-150. 10.1046/j.1525-1438.2000.00007.x.CrossRef
16.
Fernandes JV, Meissner RV, Carvvalho MGF, Fernandes TAAM, Azevedo PRM, Sobrinho SJ, Prado JCM, Villa LL: Prevalence of human papillomavirus in archival samples obtained from patients with cervical pre-malignant and malignant lesions from Northeast Brazil. BMC Res Notes. 2010, 3: 96-10.1186/1756-0500-3-96.CrossRefPubMedPubMedCentral
17.
18.
FIGO: The new FIGO staging system for cancers of the vulva, cervix, endometrium and sarcomas. Gynecol Oncol. 2009, 115: 325-328. 10.1016/j.ygyno.2009.10.050.CrossRef
19.
Rabelo-Santos SH, Zeferino L, Villa LL, Sobrinho JP, Amaral RG, Magalhães AV: Human Papillomavirus Prevalence among Women with Cervical Intraepithelial Neoplasia III and Invasive Cervical Cancer from Goiânia, Brazil. Mem Inst Oswaldo Cruz. 2003, 98: 181-184.CrossRefPubMed
20.
Bosch FX, Manos MM, Muñoz N, Sherman M, Jansesn AM, Peto J, Schiffman MH, Moreno V, Kurman R, Shah KV, International Biological Study on Cervical Cancer (IBSCC) Study Group: Prevalence of Human Papillomavirus in Cervical Cancer: a Worldwide Perspective. J Natl Cancer Inst. 1995, 87: 796-802. 10.1093/jnci/87.11.796.CrossRefPubMed
21.
Smith JS, Lindsay L, Hoots B, Keys J, Franceschi S, Winer R, Clifford GM: Human papillomavirus type distribution in invasive cervical cancer and high-grade cervical lesions: A meta-analysis update. Int J Cancer. 2007, 121: 621-632. 10.1002/ijc.22527.CrossRefPubMed
22.
Kasamatsu E, Cubilla AL, Alemany L, Chaux A, Tous S, Mendoza L, Paez M, Klaustermeier JE, Quint W, Lloveras B, De Sanjosé S, Muñoz N, Bosch FX: Type-Specific Human Papillomavirus Distribution in Invasive Cervical Carcinomas in Paraguay. A Study of 432 Cases. J Med Virol. 2012, 84: 1628-1635. 10.1002/jmv.23373.CrossRefPubMed
23.
Greer CE, Lund JK, Manos MM: PCR Amplification from Paraffin-embedded Tissues: Recommendations on Fixatives for Long-term Storage and Prospective Studies. Genome Res. 1991, 1: 46-50. 10.1101/gr.1.1.46.CrossRef
24.
Levi JE, Rahal P, Sarkis AS, Villa L: Human papillomavirus DNA and p53 status in penile carcinomas. Int J Cancer. 1998, 76: 779-783. 10.1002/(SICI)1097-0215(19980610)76:6<779::AID-IJC1>3.0.CO;2-V.CrossRefPubMed
25.
Dalstein V, Merlin S, Bali C, Saunier M, Dachez R, Ronsin C: Analytical evaluation of the PapilloCheck test, a new commercial DNA chip for detection and genotyping of human papillomavirus. J Virol Methods. 2009, 156: 77-83. 10.1016/j.jviromet.2008.11.002.CrossRefPubMed
26.
Campbell CMP, Curado MP, Harlow SD, Soliman AS: Regional variation in histopathology-specific incidence of invasive cervical cancer among Peruvian women. Int J Gyn Obst. 2012, 116: 47-51. 10.1016/j.ijgo.2011.08.008.CrossRef
27.
Castellsagué X, Díaz M, De Sanjosé S, Muñoz N, Herrero R, Franceschi S, Peeling RW, Ashley R, Smith JS, Snijders JF, Meijer CJLM, Bosch FX: Worldwide Human Papillomavirus Etiology of Cervical Adenocarcinoma and Its Cofactores: Implications for Screening and Prevention. J Natl Cancer Inst. 2006, 98: 303-315. 10.1093/jnci/djj067.CrossRefPubMed
28.
Oliveira CM, Aguiar LS, Genta MLDN, Alves VAF, Levi JE: HPV-11 associated metastatic cervical cancer. Gynecol Oncol Reports. 2012, 2: 18-19. 10.1016/j.gynor.2011.11.004.CrossRef
29.
Vinokurova S, Wwntzensen N, Kraus I, Kales R, Driesch C, Melssheimer P, Kisseljov F, Dürst M, Schneider A, Von Knebel Doeberitz M: Type-dependent integration frequency of human papillomavirus genome in cervical lesions. Cancer Res. 2008, 68: 307-313. 10.1158/0008-5472.CAN-07-2754.CrossRefPubMed
Metadata
Title
Human papillomavirus genotypes distribution in 175 invasive cervical cancer cases from Brazil
Authors
Cristina Mendes de Oliveira
José Humberto Tavares Guerreiro Fregnani
Jesus Paula Carvalho
Adhemar Longatto-Filho
José Eduardo Levi
Publication date
01-12-2013
Publisher
BioMed Central
Published in
BMC Cancer / Issue 1/2013
Electronic ISSN: 1471-2407
DOI
https://doi.org/10.1186/1471-2407-13-357

Other articles of this Issue 1/2013

BMC Cancer 1/2013 Go to the issue

Research article

Loss of Akt1 or Akt2 delays mammary tumor onset and suppresses tumor growth rate in MTB-IGFIR transgenic mice

Research article

Prognostic impact of tumor infiltrating CD8+ T cells in association with cell proliferation in ovarian cancer patients - a study of the OVCAD consortium

Research article

The Wnt signalling pathway is upregulated in an in vitro model of acquired tamoxifen resistant breast cancer

Research article

Preoperative core needle biopsy is accurate in determining molecular subtypes in invasive breast cancer

Research article

Decreased miR-106a inhibits glioma cell glucose uptake and proliferation by targeting SLC2A3 in GBM

Research article

High-risk human papillomavirus (HPV) DNA sequences in metaplastic breast carcinomas of Mexican women
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits